3 Years After Pegcetacoplan Approval:
Addressing Post-Injection Complications and Understanding EZ:RPE Loss
as a Potential Measure of Clinical Response
Sharon Fekrat, MD, FASRS; Roger A. Goldberg, MD, MBA; Deepak Sambhara, MD, FASRS; and Rishi P. Singh, MD
